Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

Clinical trial NCT02700841 · TERMINATED

Trial details

NCT number: NCT02700841
Sponsor: University of Nebraska
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Plasma Cell Myeloma

Start date: 2020-01-09
Primary completion: 2022-12-21
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.